44 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Cidara Therapeutics, Inc. CDTX shares climbed 53% to $2.57 after the company announced it has formed a partnership with Mundipharma to develop and commercialize Rezafungin. Cidara will receive an upfront payment of $30 million and an equity investment of $9 million.
• Ardelyx, Inc. ARDX shares gained 28.8% to $4.38 after the company's pivotal phase 3 AMPLIFY study of tenapanor in combination with phosphate binders in patients with chronic kidney disease met primary and all key secondary endpoints.
• MAM Software Group, Inc. MAMS gained 15.2% to $12.04 after the company announced it has agreed to be acquired by Kerridge Commercial Systems for $12.12 per share in cash.
• Endeavour Silver Corp. EXK climbed 14.4% to $3.0191.
• Emergent BioSolutions Inc. EBS climbed 14.2% to $50.03 after the company was awarded a 10-year HHS contract to deliver ACAM2000 smallpox vaccine to the U.S. Strategic National Stockpile.
• Conn's, Inc. CONN rose 14.1% to $23.01 as the company reported better-than-expected Q2 earnings.
• Reven Housing REIT, Inc. RVEN gained 12.7% to $4.96.
• Zealand Pharma A/S ZEAL rose 12% to $21.50. Boehringer Ingelheim and Zealand Pharma announced plans to initiate Phase 2 development of the GLP-1/glucagon dual agonist BI 456906.
• Afya Limited AFYA gained 11.9% to $24.50 after the company issued 2H guidance.
• Net Element, Inc. NETE rose 11.9% to $5.35.
• InMode Ltd. INMD shares climbed 10.3% to $21.95.
• Hebron Technology Co., Ltd. HEBT gained 10.1% to $3.50.
• Alexco Resource Corp. AXU rose 8.4% to $2.58
• SeaChange International, Inc. SEAC climbed 7.7% to $2.4991.
• The Medicines Company MDCO rose 5.5% to $44.26 after the company presented results from its ORION-11 trial at ESC Congress 2019. In the trial, inclisiran met all primary and secondary efficacy endpoints.

Check out these big penny stock gainers and losers

Losers

• Aridis Pharmaceuticals, Inc. ARDS dropped 17% to $9.70. Aridis announced ahead of the market open that its first-in patient Phase 2 study that evaluated its AR-105 did not meet theprimary endpoint of demonstrating superiority in clinical cure rates on Day 21 compared to placebo. The drug is a fully human IgG1 monoclonal antibody for ventilator-associated pneumonia, or VAP, caused by gram-negative Pseudomonas aeruginosa. Additionally, the company said it noted a statistically significant imbalance in all-cause mortality, as well as serious adverse event, or SAE, rates between the treatment groups that favored placebo. Aridis said it will no longer allocate further resources for the clinical development of AR-105.
• Navios Maritime Holdings Inc. NM dipped 16.6% to $5.27.
• Napco Security Technologies, Inc. NSSC shares tumbled 16.5% to $28.78 after the company reported Q4 results.
• Cleveland-Cliffs Inc. CLF shares fell 13.2% to $6.89.
• California Resources Corporation CRC tumbled 13% to $8.52.
• Liquidia Technologies, Inc. LQDA fell 12.3% to $3.56.
• Fang Holdings Limited SFUN dipped 11.6% to $1.83.
• The Goldfield Corporation GV shares tumbled 10.8% to $2.14.
• Vapotherm, Inc. VAPO shares fell 10.3% to $10.40.
• Signet Jewelers Limited SIG dropped 10.3% to $10.98.
• Pintec Technology Holdings Limited PT shares dipped 10.3% to $2.7973 after entering into a loan agreement with Shanghai Mantu Technology Co. Ltd.
• PhaseBio Pharmaceuticals, Inc. PHAS dropped 10.3% to $7.75.
• Mallinckrodt plc MNK fell 10.2% to $2.3247 after declining 15.91% on Friday.
• Evolent Health, Inc. EVH dropped 10% to $6.18.
• Nine Energy Service, Inc. NINE shares declined 10% to $4.93.
• Intelsat S.A. I fell 9.7% to $18.67 after Eutelsat withdrew from the C-Band Alliance with Intelsat and SES.
• Bed Bath & Beyond Inc. BBBY dropped 9.7% to $8.73.
• ShockWave Medical, Inc. SWAV dipped 9.6% to $37.83. Shockwave received FDA Breakthrough Device Designation for the Coronary IVL System.
• Global Cord Blood Corporation CO shares fell 9.5% to $4.58.
• Barnes & Noble Education, Inc. BNED dropped 9.5% to $3.53.
• Sasol Limited SSL fell 9.4% to $17.12.
• The Michaels Companies, Inc. MIK dropped 9.1% to $5.16.
• Fuwei Films (Holdings) Co., Ltd. FFHL fell 7.9% to $3.50.
• ProPetro Holding Corp. PUMP dropped 6.8% to $9.93 after Piper Jaffray downgraded the stock from Overweight to Neutral and lowered the price target from $32.5 to $17.
• BioLineRx Ltd. BLRX fell 6.3% to $2.67. BioLineRx disclosed that it has successfully completed dose-escalation part of Phase 1/2a clinical study for AGI-134 immunotherapy for the treatment of solid tumors.
• Seadrill Limited SDRL fell 5.5% to $2.22 after dropping 6.75% on Friday.
• Mattel, Inc. MAT dropped 5.3% to $9.28 after some of the 15% tariffs on $112 billion worth of Chinese goods went into effect on Sunday.
• MoSys, Inc. MOSY fell 5.3% to $2.52 after rising 5.56% on Friday.
• Tata Motors Limited TTM dropped 5% to $7.81 in sympathy with the overall Indian market. The Sensex suffered its biggest fall this year potentially over concerns of economic growth slowing.